Plus Therapeutics (PSTV) Institutional Ownership $0.30 +0.00 (+1.38%) Closing price 07/7/2025 04:00 PM EasternExtended Trading$0.30 0.00 (-0.17%) As of 07/7/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Plus Therapeutics (NASDAQ:PSTV)CurrentInstitutional OwnershipPercentage3.28%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$873.99KNumber ofInstitutional Sellers(last 12 months)0 Get PSTV Insider Trade Alerts Want to know when executives and insiders are buying or selling Plus Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PSTV Institutional Buying and Selling by Quarter Plus Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/12/2025Virtu Financial LLC40,030$38K0.0%N/A0.235% 8/7/2024AIGH Capital Management LLC568,681$836K0.3%N/A9.977% 11/15/2022Parkman Healthcare Partners LLC1,325,025$590K0.2%-13.6%3.943% 8/8/2022Otter Creek Advisors LLC330,168$178K0.1%+293.5%1.465% 5/13/2022Parkman Healthcare Partners LLC1,526,316$1.53M0.4%N/A6.875% 5/9/2022Otter Creek Advisors LLC83,901$84K0.0%N/A0.378% 11/9/2021BlackRock Inc.128,323$245K0.0%-19.7%0.835% 9/17/2021Virtu Financial LLC76,187$195K0.0%N/A0.630% 8/16/2021State Street Corp34,214$88K0.0%N/A0.283% 8/13/2021Renaissance Technologies LLC17,607$45K0.0%N/A0.146% 8/13/2021Northern Trust Corp40,524$104K0.0%N/A0.335% 8/13/2021Geode Capital Management LLC130,793$334K0.0%N/A1.082% 8/13/2021Vanguard Group Inc.712,847$1.83M0.0%+824.7%5.897% 8/12/2021Dimensional Fund Advisors LP68,430$175K0.0%N/A0.566% 8/11/2021Susquehanna Fundamental Investments LLC13,033$33K0.0%N/A0.108% (Data available from 1/1/2016 forward) PSTV Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PSTV shares? During the previous two years, the following institutional investors and hedge funds held shares of Plus Therapeutics shares: AIGH Capital Management LLC ($836K), Virtu Financial LLC ($38K).Learn more on Plus Therapeutics' institutional investors. What percentage of Plus Therapeutics' stock is owned by institutional investors? 3.28% of Plus Therapeutics' stock is owned by institutional investors. Learn more on PSTV's institutional investor holdings. Which institutional investors have been buying Plus Therapeutics' stock? The following institutional investors have purchased Plus Therapeutics' stock in the last 24 months: AIGH Capital Management LLC ($568.68K), and Virtu Financial LLC ($40.03K). How much institutional buying is happening at Plus Therapeutics? Institutional investors have bought a total of 608,711 shares in the last 24 months. This purchase volume represents approximately $873.99K in transactions. Related Companies EDAP TMS Institutional Ownership Hyperfine Institutional Ownership IceCure Medical Institutional Ownership Carmell Institutional Ownership Spectral AI Institutional Ownership Alpha Pro Tech Institutional Ownership Milestone Scientific Institutional Ownership Daxor Institutional Ownership Nephros Institutional Ownership Safe Pro Group Institutional Ownership This page (NASDAQ:PSTV) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredInstant Cash (in 4 clicks)Since 1973, Wall Street has quietly used a strange little pricing quirk to cash flow billions. Now, for the...Awesomely, LLC | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Plus Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Plus Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PSTV Stock Alerts